Objective: This study aimed to determine the presence of carbapenem-resistant Klebsiella pneumoniae in nosocomial infections in Latin America and to analyze its frequency and tendency in Latin America.
Methods: This study is a literature review; it was carried out through exhaustive research in different databases, Analytical and descriptive cohort studies, meta-analysis, and some clinical trials related to the presence of nosocomial infections caused by carbapenem-resistant K. pneumoniae and the genes responsible for this resistance were included.
Results: Twenty-two articles were selected from different databases from Latin American countries; In addition, the percentages of resistance to carbapenems in K. pneumoniae in these countries and its trend before and during the COVID-19 pandemic were identified.
Conclusions Resistance to carbapenems in K. pneumoniae was determined as a public health problem in Latin America, considered a limiting factor in treating patients with infections caused by Enterobacter. In addition, it was identified that KPC is the main gene responsible for carbapenem resistance.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.